Navigation Links
Alliqua's CEO Issues Midyear Corporate Update for Shareholders
Date:7/30/2013

eness around the hydrogel products we have in Hydress® and Silverseal®, as we look to significantly ramp our proprietary product sales heading into 2014. As mentioned in our recent press release, our clinical trial results to date for foot and ankle surgery are very exciting, as they clearly demonstrate the clinical benefits of our products. We are very optimistic about this market since superior products, coupled with a strong distribution network, are the key ingredients to building strong sustainable revenue growth. We believe the seeds we are planting today will enable us to reap rewards for many years to come.

3) Expanding Our Wound Care Portfolio of Products and Technologies

As we have discussed in the past, our vision remains to build a diversified wound care company, building a suite of technological solutions that will allow wound care practitioners to solve the challenges that are presented to them in both chronic and acute wounds. We have been encouraged about the discussions that we have had with potential strategic partners to enhance our portfolio, and will continue to report on our progress.

4) Building the Value Proposition and Proof of Principle of Our Hydrogel Technology for Topical and Transdermal Drug Delivery

Our plan to leverage our hydrogel technology as an effective drug delivery mechanism continues to be developed in parallel with our wound care initiatives. In fact, last week we announced  the launch of a proof of principle study to demonstrate the effectiveness of lidocaine in a hydrogel patch. The results of this study will be announced once they are available. We are very excited about the possibility of entering into this large and growing marketplace.

5) Optimizing Our Hepalife Intellectual Pr
'/>"/>

SOURCE Alliqua, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Father Who Lost Young Children Files Ballot Initiative To Address Patient Safety Issues Behind Deaths
2. CTI Issues Statement Regarding Tosedostat Clinical Trial
3. Lilly Issues Alert for Illegal Scams Involving Fraudulent Checks and Online Job Requests
4. Celsion Corporation Issues Statement Regarding Misleading Blog Entry
5. Zydus Pharmaceuticals USA Inc. Issues Voluntary Nationwide Recall of Warfarin 2 mg Tablets, Lot MM5767, Expiration Date June 2014, Due to Oversized Tablets
6. Endeavor Power Corporation Issues Corrections on two of its earlier Press Releases dated January 9, 2013 and March 8, 2013
7. Neiman Center Issues Policy Brief Outlining Innovative Health Care Payment Models to Provide Cost-Effective Specialty Care for Patients
8. ISPE Patient Initiative Issues Survey Regarding Patient Experience with Clinical Materials
9. Ampio Pharmaceuticals Issues Statement Regarding Misleading Blog
10. American Academy of Ophthalmology Issues Statement on Provisions to Pharmaceutical Compounding Quality and Accountability Act
11. Royalty Pharma Issues Investor Presentation Highlighting The Strategic And Financial Advantages Of Its Offer To Acquire Elan For $12.50 Per Share In Cash
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... - The Canadian Epilepsy Alliance (CEA) is thrilled to announce ... children about the most common neurological disorder in ... comic series tells a fictional story based on the experiences ... with epilepsy. "Despite the fact that epilepsy ... misinformation and lack of awareness out there," says Gail ...
(Date:8/21/2014)... , Aug. 21, 2014  IBM (NYSE: IBM ... ( DESY ), a leading national research center in ... and storage of massive volumes of x-ray data. The ... on IBM software defined technology can handle more than ... and help scientists worldwide gain faster insights into the ...
(Date:8/21/2014)... , Aug. 21, 2014  Zacks.com announces the list of ... Equity Research analysts discuss the latest news and events impacting ... blog include the Hewlett-Packard (NYSE: HPQ - Free Report ), ... Inc. (NYSE: SB - Free Report ), GlaxoSmithKline plc ... N.V. (NYSE: FI - Free Report ). ...
Breaking Medicine Technology:Action Heroes Harness Powers to Educate Children About Epilepsy 2Action Heroes Harness Powers to Educate Children About Epilepsy 3DESY and IBM Develop Big Data Architecture for Science 2DESY and IBM Develop Big Data Architecture for Science 3The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 2The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 3The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 4The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 5The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 6The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 7The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 8The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 9The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 10The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 11
... March 29, 2011 Boston Scientific Corporation (NYSE: ... and events schedule at the 60th Annual Scientific Session ... 2011 in New Orleans. "Twelve-month results from ... on our next-generation PROMUS Element™ Everolimus-Eluting Platinum Chromium (PtCr) ...
... Calif., March 29, 2011 CryoLife, Inc. (NYSE: ... cardiovascular tissue processing company, and Cardiogenesis Corporation (OTCQB: CGCP), ... treatment of patients with refractory angina resulting from diffuse ... directors of both companies have approved a definitive agreement ...
Cached Medicine Technology:Boston Scientific Announces Its ACC 2011 Schedule 2Boston Scientific Announces Its ACC 2011 Schedule 3Boston Scientific Announces Its ACC 2011 Schedule 4Boston Scientific Announces Its ACC 2011 Schedule 5Boston Scientific Announces Its ACC 2011 Schedule 6CryoLife Signs Definitive Agreement to Acquire Cardiogenesis 2CryoLife Signs Definitive Agreement to Acquire Cardiogenesis 3CryoLife Signs Definitive Agreement to Acquire Cardiogenesis 4CryoLife Signs Definitive Agreement to Acquire Cardiogenesis 5CryoLife Signs Definitive Agreement to Acquire Cardiogenesis 6CryoLife Signs Definitive Agreement to Acquire Cardiogenesis 7CryoLife Signs Definitive Agreement to Acquire Cardiogenesis 8CryoLife Signs Definitive Agreement to Acquire Cardiogenesis 9CryoLife Signs Definitive Agreement to Acquire Cardiogenesis 10CryoLife Signs Definitive Agreement to Acquire Cardiogenesis 11CryoLife Signs Definitive Agreement to Acquire Cardiogenesis 12CryoLife Signs Definitive Agreement to Acquire Cardiogenesis 13CryoLife Signs Definitive Agreement to Acquire Cardiogenesis 14CryoLife Signs Definitive Agreement to Acquire Cardiogenesis 15CryoLife Signs Definitive Agreement to Acquire Cardiogenesis 16CryoLife Signs Definitive Agreement to Acquire Cardiogenesis 17CryoLife Signs Definitive Agreement to Acquire Cardiogenesis 18
(Date:8/22/2014)... FL (PRWEB) August 22, 2014 This ... cell therapy research affiliate, Saneron CCEL Therapeutics, Inc. in ... , “Cryo-Cell is extremely pleased to collaborate with Saneron ... IND, which we hope will lead to regenerative ... diseases such as ALS,” David Portnoy, Chairman and Co-CEO ...
(Date:8/22/2014)... 2014 (HealthDay News) -- The air in American cities ... Agency reported Thursday. Significant progress has been made ... in recent decades, the agency said in a news ... 60 percent reduction in mercury from human sources such ... and an 84 percent fall in lead, which harms ...
(Date:8/22/2014)... may reduce addiction without increasing exposure to toxic ... University of Waterloo. , The study published ... the smoking behaviours of 72 adults as they ... reduced nicotine levels. , Unlike when smokers switch ... similar levels of nicotine contentthe study found no ...
(Date:8/22/2014)... (PRWEB) August 22, 2014 Goats are taking ... Milk Foods, attends the 10th annual Pre-Emmy Awards Boom Boom ... to try the best new products for kids on August ... 4 p.m., and we’ll be encouraging them to #GoGoat for ... so excited to present our gentle, non-GMO goat milk foods ...
(Date:8/22/2014)... (PRWEB) August 22, 2014 For the ... employee reward and recognition industry, has received a prestigious ... extraordinary growth rate of 134%, TharpeRobbins remains on the ... North America. TharpeRobbins was previously on the list in ... to be included in this distinguished list for a ...
Breaking Medicine News(10 mins):Health News:Cryo-Cell Provides Funding for Cord Blood Clinical Trial Application to Treat ALS 2Health News:Cryo-Cell Provides Funding for Cord Blood Clinical Trial Application to Treat ALS 3Health News:Air in U.S. Cities Getting Cleaner, EPA Says 2Health News:Smokers consume same amount of cigarettes regardless of nicotine levels 2Health News:#GoGoat with Kabrita at the Pre-Emmy Awards Boom Boom Room 2Health News:For The Fourth Time - TharpeRobbins Earns A Place On Prestigious Inc. Magazine 500|5000 List 2Health News:For The Fourth Time - TharpeRobbins Earns A Place On Prestigious Inc. Magazine 500|5000 List 3
... July 9, 2009 The President of the ... statement today on President Obama,s nomination of Francis Collins, M.D., ... Health (NIH):,"At no other time in recent memory has there ... in the power of science to deliver solutions to the ...
... Bioheart, Inc. (OTC Bulletin Board: BHRT) (the "Company") ... July 7, 2009, Bioheart, Inc. (the "Company") has received proceeds ... common stock and warrants under its current offering under Regulation ... Common Stock to be issued in connection with the Offering ...
... Parsippany took top honors in the state,s first-ever 100-day ... on June 2nd. With participating residents losing an average of ... pounds, Parsippany was presented with a plaque and Morris County ... , Residents throughout northern and central New Jersey also participated ...
... , ... and Directory Helps Attendees and Exhibitors,Connect at AAMSE Conference and Beyond. , ... Arlington, VA (PRWEB) July 9, 2009 -- MarketArt ... enhanced attendee experience at the American Association of Medical Society Executives (AAMSE) 2009 ...
... Institute of Technology (Caltech) and the Scripps Research Institute have ... chemicals that have the potential to take the place of ... James R. Heath, the Elizabeth W. Gilloon Professor and ... M. Keck Professor of Chemistry at the Scripps Research Institute ...
... United States Senate Committee on Small Business ... Member Olympia J. Snowe, R-Maine, today convened a ... relate to small businesses. Participants at the roundtable, ... the Perspective of Small Businesses," included U.S. Sen. ...
Cached Medicine News:Health News:Bioheart, Inc. Announces Receipt of $2.8 Million in Proceeds From Pipe Financing 2Health News:Bioheart, Inc. Announces Receipt of $2.8 Million in Proceeds From Pipe Financing 3Health News:Parsippany Takes Top Honors in New Jersey's First-Ever Toxic Waistlines Contest 2Health News:Parsippany Takes Top Honors in New Jersey's First-Ever Toxic Waistlines Contest 3Health News:MarketArt to Enhance Attendee Experience at AAMSE Annual Conference 2Health News:MarketArt to Enhance Attendee Experience at AAMSE Annual Conference 3Health News:Caltech chemists say antibody surrogates are just a 'click' away 2Health News:Caltech chemists say antibody surrogates are just a 'click' away 3Health News:Landrieu, Snowe Convene Roundtable on Healthcare for Small Businesses 2Health News:Landrieu, Snowe Convene Roundtable on Healthcare for Small Businesses 3
Nature's Remarkable Skin Protector -- Karaya 5 is a natural skin barrier that is particularly well suited for skin problems or for sensitive skin where reactions may have occurred to other types of s...
Protects skin from corrosive drainage with the standard wear, FlexWear skin barrier. Security and confidence assured with porous tape, internal non-reflux valves, convenient drain valve....
Inquire...
Inquire...
Medicine Products: